Hm Payson & CO Organon & Co. Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Organon & Co. stock. As of the latest transaction made, Hm Payson & CO holds 1,714 shares of OGN stock, worth $26,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,714

Previous 1,343 27.62%

Holding current value

$26,189

Previous $27,000 18.52%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$18.65 - $23.03 $6,919 - $8,544	371 Added 27.62%	1,714 $32,000
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $1,221 - $1,537	70 Added 5.5%	1,343 $27,000
Q1 2024 Jun 20, 2024	SELL	$13.78 - $18.8 $151 - $206	-11 Reduced 0.86%	1,273 $23,000
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $20,148 - $31,868	-1,840 Reduced 58.9%	1,284 $18,000
Q3 2023 Nov 06, 2023	SELL	$16.59 - $23.77 $7,647 - $10,957	-461 Reduced 12.86%	3,124 $54,000
Q2 2023 Jul 17, 2023	SELL	$19.27 - $24.63 $6,416 - $8,201	-333 Reduced 8.5%	3,585 $74,000
Q1 2023 Apr 18, 2023	SELL	$21.42 - $32.08 $3,384 - $5,068	-158 Reduced 3.88%	3,918 $92,000
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $44,405 - $54,502	-1,905 Reduced 31.85%	4,076 $113,000
Q3 2022 Oct 25, 2022	SELL	$23.4 - $34.25 $24,897 - $36,442	-1,064 Reduced 15.1%	5,981 $140,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $108,942 - $133,854	-3,441 Reduced 32.82%	7,045 $237,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $93,603 - $120,992	-3,074 Reduced 22.67%	10,486 $367,000
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $162,358 - $210,267	-5,663 Reduced 29.46%	13,560 $413,000
Q3 2021 Nov 30, 2021	SELL	$28.63 - $35.64 $100,720 - $125,381	-3,518 Reduced 15.47%	19,223 $630,000
Q2 2021 Aug 17, 2021	BUY	$28.45 - $38.0 $646,981 - $864,158	22,741 New	22,741 $688,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account